Bengaluru-based Lumos Health Advisory has officially opened applications for its second cohort of early-stage healthcare startups. The startups working in high-impact healthtech and medtech domains are invited to apply before the application deadline of 25 June 2026.
Lumos Health is powered by a strategic partnership between Anjali Ajaikumar, Director of HCG and Anthill Ventures, a global $100 million fund with strong investor and business networks spanning India, USA and Singapore. Together, they offer participating startups an unmatched combination of clinical infrastructure and commercial scale.
This initiative is open to startups from across the globe. Through Lumos Health's partner hospital network and various partner, startups gain access to clinical trial support and real-world validation - enabling them to reach market significantly faster than through conventional routes.
Accepted startups benefit from a comprehensive package of support including regulatory navigation, market access, clinical validation, capital and funding, expert mentorship, cohort sessions along with Infrastructure support.
Solutions leveraging IoT-enabled remote monitoring, artificial intelligence and predictive analytics, self-testing, image-based pathology, blockchain, and medical big data are also strongly encouraged to apply.
The first cohort of Lumos Health demonstrated the programme's potential to unlock synergies between innovative startups and the broader healthcare ecosystem. Alumni include companies such as ErlySign, RayIoT, KroniKare, AyuRhythm, Deep Holistics - all having benefited from Lumos Health’s clinical networks and Anthill's investor relationships.
Lumos sits at a critical intersection - between seed stage and early expansion - where founders need the most hands-on support and the programme is designed precisely for that inflection point. In the past, Lumos has reviewed 500+ startups, had 350+ applications, and accepted 8 startups into its portfolio.